SCP2 Gene Leukoencephalopathy with dystonia and motor neuropathy Genetic Test sale cost 4400 AED
MT-ND3 Gene Leigh syndrome due to mitochondrial complex I deficiency Genetic Test sale cost 4400 AED MT-ND3 Gene Leigh syndrome due to mitochondrial complex I deficiency Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
ANO5 Gene Limb-girdle muscular dystrophy autosomal recessive type 2L Genetic Test sale cost 4400 AED ANO5 Gene Limb-girdle muscular dystrophy autosomal recessive type 2L Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

SCP2 Gene Leukoencephalopathy with dystonia and motor neuropathy Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “SCP2 Gene Leukoencephalopathy with Dystonia and Motor Neuropathy Genetic Test” is a specialized diagnostic evaluation available at DNA Labs UAE, designed to identify mutations in the SCP2 gene, which are implicated in the development of leukoencephalopathy with dystonia and motor neuropathy. This condition is a rare neurological disorder characterized by changes in the brain’s white matter, leading to dystonia (involuntary muscle contractions), motor neuropathy (nerve damage affecting muscle control), and a range of other neurological symptoms.

The test is crucial for individuals showing symptoms of the disorder or those with a family history, as it helps in confirming the diagnosis, understanding the progression of the disease, and planning appropriate management and treatment strategies. The process involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory to detect mutations in the SCP2 gene.

At DNA Labs UAE, this comprehensive genetic test is offered at a cost of 4400 AED. The price reflects the sophisticated technology and expertise required to accurately identify the genetic alterations associated with this complex condition. The results from this test can provide essential insights for affected individuals and their families, guiding clinical decisions and offering information on the genetic risk for future generations.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

SCP2 Gene Leukoencephalopathy with dystonia and motor neuropathy Genetic Test

At DNA Labs UAE, we offer the SCP2 Gene Leukoencephalopathy with dystonia and motor neuropathy Genetic Test at a cost of AED 4400.0. This test is specifically designed to diagnose individuals with suspected Leukoencephalopathy with dystonia and motor neuropathy (LDMN) by analyzing the SCP2 gene using NGS (Next-Generation Sequencing) technology.

Test Components and Price

The SCP2 Gene Leukoencephalopathy with dystonia and motor neuropathy Genetic Test includes the following components:

  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics

The cost of the test is AED 4400.0.

Pre Test Information

Before undergoing the SCP2 Gene Leukoencephalopathy with dystonia and motor neuropathy Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected with LDMN. This information helps in providing accurate results and guidance for treatment and family planning.

About Leukoencephalopathy with dystonia and motor neuropathy (LDMN)

LDMN is a rare neurodegenerative disorder characterized by progressive dystonia, motor neuropathy, and leukoencephalopathy. Individuals with LDMN experience involuntary muscle contractions, damage to the nerves controlling movement, and abnormalities in the white matter of the brain.

NGS Genetic Testing for LDMN

NGS genetic testing is a powerful technique used to analyze multiple genes simultaneously to identify mutations or variations associated with genetic disorders. In the case of LDMN, NGS testing can specifically identify mutations or variations in the SCP2 gene that may be responsible for the disorder.

By analyzing the SCP2 gene using NGS, healthcare professionals can provide a definitive diagnosis for individuals suspected of having LDMN. This diagnosis is crucial for guiding treatment decisions, providing genetic counseling, and assisting in family planning.

Research and Future Developments

NGS testing for LDMN not only aids in diagnosis and treatment decisions but also contributes to ongoing research efforts. By understanding the genetic basis of LDMN through NGS testing, researchers can potentially develop targeted therapies in the future.

At DNA Labs UAE, we are committed to providing accurate and reliable genetic testing services. Our SCP2 Gene Leukoencephalopathy with dystonia and motor neuropathy Genetic Test offers a comprehensive analysis that can make a significant impact on the lives of individuals and families affected by LDMN.

Test Name SCP2 Gene Leukoencephalopathy with dystonia and motor neuropathy Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for SCP2 Gene Leukoencephalopathy with dystonia and motor neuropathy NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with SCP2 Gene Leukoencephalopathy with dystonia and motor neuropathy
Test Details

The SCP2 gene is associated with a rare genetic disorder called Leukoencephalopathy with dystonia and motor neuropathy (LDMN). LDMN is a neurodegenerative disorder characterized by a combination of symptoms including progressive dystonia (involuntary muscle contractions), motor neuropathy (damage to the nerves that control movement), and leukoencephalopathy (abnormalities in the white matter of the brain).

NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze multiple genes simultaneously to identify mutations or variations that may be responsible for a particular genetic disorder. In the case of LDMN, NGS genetic testing can be used to identify mutations or variations in the SCP2 gene that may be causing the disorder.

By analyzing the SCP2 gene using NGS, healthcare professionals can provide a definitive diagnosis for individuals with suspected LDMN. This can help guide treatment decisions and provide important information for genetic counseling and family planning. Additionally, NGS testing can also be used for research purposes to further understand the genetic basis of LDMN and potentially develop targeted therapies in the future.

SKU: TEST-1516 Category:

Related products